LEADER 06212nam 2200769Ia 450 001 9910973562703321 005 20251017110143.0 010 $a9786610183074 010 $a9780309168915 010 $a0309168910 010 $a9781280183072 010 $a1280183071 010 $a9780309566384 010 $a030956638X 035 $a(CKB)111069351129718 035 $a(EBL)3377245 035 $a(SSID)ssj0000176893 035 $a(PQKBManifestationID)12020325 035 $a(PQKBTitleCode)TC0000176893 035 $a(PQKBWorkID)10209480 035 $a(PQKB)11222396 035 $a(MiAaPQ)EBC3377245 035 $a(Au-PeEL)EBL3377245 035 $a(CaPaEBR)ebr10068487 035 $a(OCoLC)70774243 035 $a(Perlego)4736674 035 $a(DNLM)1207599 035 $a(BIP)10291248 035 $a(EXLCZ)99111069351129718 100 $a20040105d2003 uy 0 101 0 $aeng 135 $aur|n|---||||| 181 $ctxt 182 $cc 183 $acr 200 00$aImmunization safety review $eSV40 contamination of polio vaccine and cancer /$fImmunization Safety Review Committee, Board on Health Promotion and Disease Prevention ; Kathleen Stratton, Donna A. Alamario [sic], and Marie C. McCormick, editors ; Institute of Medicine of the National Academies 205 $a1st ed. 210 $aWashington, D.C. $cNational Academies Press$dc2003 215 $a1 online resource (118 p.) 300 $aDescription based upon print version of record. 311 08$a9780309086103 311 08$a0309086108 320 $aIncludes bibliographical references. 327 $aIMMUNIZATION SAFETY REVIEW; Copyright; REVIEWERS; Foreword; Acknowledgments; Contents; Executive Summary; ABSTRACT; THE FRAMEWORK FOR SCIENTIFIC ASSESSMENT; Causality; Biological Mechanisms; SV40 Contamination of Polio Vaccine; SCIENTIFIC ASSESSMENT; Causality; Biological Mechanisms; Is SV40 a Transforming Virus?; Can SV40 Cause Cancer in Humans under Conditions of Natural Exposure?; Is Contamination of the Polio Vaccine with SV40 Responsible for SV40 Infection in Humans?; SIGNIFICANCE ASSESSMENT; RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE; Policy Analysis and Communication; Research 327 $aREFERENCESImmunization Safety Review: SV40 Contamination of Polio Vaccine and Cancer; THE CHARGE TO THE COMMITTEE; THE STUDY PROCESS; THE FRAMEWORK FOR SCIENTIFIC ASSESSMENT; Causality; Biological Mechanisms; Published and Unpublished Data; UNDER REVIEW: SV40 CONTAMINATION OF POLIO VACCINE AND CANCER; Polio Vaccines and SV40; Cancers; Mesothelioma; Osteosarcoma; Ependymoma; Non-Hodgkin's Lymphoma; SCIENTIFIC ASSESSMENT; Causality; Cancer Incidence; Ecologic Studies; Controlled Observational Studies; Cancer Mortality; Ecologic Studies; Uncontrolled Observational Studies 327 $aPrenatal Exposure to Polio Vaccine Containing SV40Controlled Observational Studies; Causality Argument; Biological Mechanisms; Is SV40 a Transforming Virus?; Can SV40 Cause Cancer in Humans under Conditions of Natural Exposure?; Is Contamination of the Polio Vaccine with SV40 Responsible for SV40 Infection in Humans?; Summary of the Scientific Assessment; SIGNIFICANCE ASSESSMENT; RECOMMENDATIONS FOR PUBLIC HEALTH RESPONSE; Policy Review; Policy Analysis and Communication; Research; SUMMARY; REFERENCES; Appendix A Committee Recommendations and Conclusions from Previous Reports 327 $aMEASLES-MUMPS-RUBELLA VACCINE AND AUTISM:Conclusions; Recommendations; Public Health Response; Policy Review; Research Regarding MMR and ASD; Communications; THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS; Conclusions; Public Health Response Recommendations; Policy Review and Analysis; Public Health and Biomedical Research; Epidemiological Research; Clinical Research; Basic Science Research; MULTIPLE IMMUNIZATIONS AND IMMUNE DYSFUNCTION; Conclusions; Scientific Assessment; Causality Conclusions; Biological Mechanisms Conclusions; Autoimmune Disease; Allergic Disease 327 $aHeterologous InfectionSignificance Assessment; Public Health Response Recommendations; Policy Review; Research; Epidemiological Research; Basic Science and Clinical Research; Communication; HEPATITIS B VACCINE AND DEMYELINATING NEUROLOGICAL DISORDERS; Causality Conclusions; Biological Mechanisms Conclusions; SIGNIFICANCE ASSESSMENT; PUBLIC HEALTH RESPONSE RECOMMENDATIONS; Policy Review; Basic and Clinical Science; Communication; Appendix B Public Meeting Agenda July 11, 2002 ; Appendix C Chronology of Important Events Regarding Vaccine Safety 330 $aThe Immunization Safety Review Committee was established by the Institute of Medicine (IOM) to evaluate the evidence on possible causal associations between immunizations and certain adverse outcomes, and to then present conclusions and recommendations. The committee's mandate also includes assessing the broader societal significance of these immunization safety issues. While all the committee members share the view that immunization is generally beneficial, none of them has a vested interest in the specific immunization safety issues that come before the group. The committee reviews three immunization safety review topics each year, addressing each one at a time. In this fifth report in a series, the committee examines the hypothesis that exposure to polio vaccine contaminated with simian virus 40 (SV40), a virus that causes inapparent infection in some monkeys, can cause certain types of cancer. 606 $aPoliomyelitis vaccine$xContamination 606 $aImmunization$xComplications 606 $aVaccination$xComplications 615 0$aPoliomyelitis vaccine$xContamination. 615 0$aImmunization$xComplications. 615 0$aVaccination$xComplications. 676 $a614.5 701 $aStratton$b Kathleen R$01797964 701 $aAlmario$b Donna A$01806832 701 $aMcCormick$b Marie C$01806833 712 02$aInstitute of Medicine (U.S.).$bImmunization Safety Review Committee. 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910973562703321 996 $aImmunization safety review$94356225 997 $aUNINA